SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Economic evaluation of COVID-19 vaccination: A systematic review
12 references·0 citing·42 second hop
Economic evaluation of COVID-19 vaccination: A systematic review (2023)Economic evaluation of COVID-19 vaccinati…Examining the unit costs of COVID-19 vaccine delivery in Kenya (2022)Examining the unit costs of C…Cost-effectiveness analysis of BNT162b2 COVID-19 booster vaccination in the United States (2022)Cost-effectiveness analysis o…Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) Statement: Updated Reporting Guidance for Health Economic Evaluations (2022)Consolidated Health Economic …The potential public health and economic value of a hypothetical COVID-19 vaccine in the United States: Use of cost-effectiveness modeling to inform vaccination prioritization (2021)The potential public health a…Economic value of vaccines to address the COVID-19 pandemic: a U.S. cost-effectiveness and budget impact analysis (2021)Economic value of vaccines to…Economic evaluation for mass vaccination against COVID-19 (2021)Economic evaluation for mass …COVID-19 vaccine access in Africa: Global distribution, vaccine platforms, and challenges ahead (2021)COVID-19 vaccine access in Af…Understanding the global measurement of willingness to pay in health (2020)Understanding the global meas…Impact of COVID-19 on vaccination programs: adverse or positive? (2020)Impact of COVID-19 on vaccina…Economic evaluation of programs against COVID-19: A systematic review (2020)Economic evaluation of progra…COVID-19: Prevention and control measures in community (2020)COVID-19: Prevention and cont…Sensitivity Analysis in Cost-Effectiveness Studies (2011)Sensitivity Analysis in Cost-…Autoregressive Conditional Heteroscedasticity with Estimates of the Variance of United Kingdom Inflation (1982)Econometric Analysis of Cross Section and Panel Data (2001)Methods for the Economic Evaluation of Health Care Programmes (2005)How Should We Deal with Patient Heterogeneity in Economic Evaluation: A Systematic Review of National Pharmacoeconomic Guidelines (2013)Cost-Effectiveness Analysis: A Proposal of New Reporting Standards in Statistical Analysis (2014)Cost-Effectiveness Analysis in Development: Accounting for Local Costs and Noisy Impacts (2015)How attractive does a new technology have to be to warrant adoption and utilization? Tentative guidelines for using clinical and economic evaluations. (1992)Updating Cost-Effectiveness — The Curious Resilience of the $50,000-per-QALY Threshold (2014)Country-Level Cost-Effectiveness Thresholds: Initial Estimates and the Need for Further Research (2016)Determinants of willingness to pay for health services: a systematic review of contingent valuation studies (2022)Economic Perspective of the Use of Wearables in Health Care: A Systematic Review (2024)Anti-vaccination movements and their interpretations (2005)Listening to the rumours: What the northern Nigeria polio vaccine boycott can tell us ten years on (2013)Vaccine hesitancy: Definition, scope and determinants (2015)Disruption of childhood vaccination during the COVID-19 pandemic in Indonesia (2021)Impact of COVID-19 pandemic on routine immunization (2021)The impact of misinformation on the COVID-19 pandemic (2022)Defining Elements of Value in Health Care—A Health Economics Approach: An ISPOR Special Task Force Report [3] (2018)La certeza de lo impredecible: Cultura Educación y Sociedad en tiempos de COVID19 (2020)Cost-Effectiveness of Interventions for the Prevention and Control of COVID-19: A Systematic Review and Meta-Analysis (2021)Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement (2009)Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement. (2009)AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both (2017)Burden of Covid-19 restrictions: National, regional and global estimates (2022)COVID-19 vaccines: how to ensure Africa has access (2020)The unequal scramble for coronavirus vaccines — by the numbers (2020)Factors Associated with COVID-19 Vaccine Intentions in Eastern Zimbabwe: A Cross-Sectional Study (2021)Feelings towards COVID-19 vaccination in Africa (2021)Barriers to COVID-19 Health Products in Low-and Middle-Income Countries During the COVID-19 Pandemic: A Rapid Systematic Review and Evidence Synthesis (2022)Coronavirus Disease 2019 (COVID-19) Pandemic across Africa: Current Status of Vaccinations and Implications for the Future (2022)US Valuation of the EQ-5D Health States (2005)Recommendations for Conduct, Methodological Practices, and Reporting of Cost-effectiveness Analyses (2016)COVID-19 and African Americans (2020)A Cost-Effectiveness Framework for COVID-19 Treatments for Hospitalized Patients in the United States (2021)Methods for the economic evaluation of health care programmes (1987)Cost-Effectiveness in Health and Medicine (1996)Consolidated Health Economic Evaluation Reporting Standards (CHEERS)—Explanation and Elaboration: A Report of the ISPOR Health Economic Evaluation Publication Guidelines Good Reporting Practices Task Force (2013)Health equity and COVID-19: global perspectives (2020)Resilient COVID-19 vaccine supply chain: An optimization and simulation approach for multi-objective management (2025)COVID-19 Knowledge, Risk Perception, and Precautionary Behavior Among Nigerians: A Moderated Mediation Approach (2020)The effect of COVID-19 pandemic on domestic tourism: A DEMATEL method analysis on quarantine decisions (2020)Green Closed-Loop Supply Chain Network Design During the Coronavirus (COVID-19) Pandemic: a Case Study in the Iranian Automotive Industry (2022)
this work references cited by second hop

References

  • 2020COVID-19: Prevention and control measures in community895 cited
  • 2020Understanding the global measurement of willingness to pay in health164 cited
  • 2021The potential public health and economic value of a hypothetical COVID-19 vaccine in the United States: Use of cost-effectiveness modeling to inform vaccination prioritization139 cited
  • 2021COVID-19 vaccine access in Africa: Global distribution, vaccine platforms, and challenges ahead127 cited
  • 2011Sensitivity Analysis in Cost-Effectiveness Studies92 cited
  • 2020Impact of COVID-19 on vaccination programs: adverse or positive?83 cited
  • 2021Economic value of vaccines to address the COVID-19 pandemic: a U.S. cost-effectiveness and budget impact analysis77 cited
  • 2022Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) Statement: Updated Reporting Guidance for Health Economic Evaluations76 cited
  • 2020Economic evaluation of programs against COVID-19: A systematic review73 cited
  • 2022Cost-effectiveness analysis of BNT162b2 COVID-19 booster vaccination in the United States61 cited
  • 2021Economic evaluation for mass vaccination against COVID-1956 cited
  • 2022Examining the unit costs of COVID-19 vaccine delivery in Kenya22 cited

Cited by

No citing works inside the corpus for this window.

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work